Sakai Chemical Industry Co., Ltd. (TYO:4078)
Japan · Delayed Price · Currency is JPY 4,000.00
-55.00 (-1.36%)
Aug 14, 2026, 3:30 PM JST
Sakai Chemical Industry Income Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 82,777 | 81,447 | 84,409 | 82,105 | 83,861 | 80,135 | |
Revenue Growth | 0.12% | -3.51% | 2.81% | -2.09% | 4.65% | -5.63% |
Cost of Revenue | 62,224 | 60,742 | 64,127 | 65,248 | 65,381 | 59,090 |
Gross Profit | 20,553 | 20,705 | 20,282 | 16,857 | 18,480 | 21,045 |
Selling, General & Admin | 14,188 | 14,141 | 14,077 | 13,789 | 13,936 | 13,416 |
Amortization of Goodwill & Intangibles | 111 | 111 | 111 | 125 | 136 | 134 |
Operating Expenses | 14,299 | 14,252 | 14,188 | 13,914 | 14,072 | 13,550 |
Operating Income | 6,254 | 6,453 | 6,094 | 2,943 | 4,408 | 7,495 |
Interest Expense | -159 | -162 | -140 | -116 | -76 | -73 |
Interest & Investment Income | 294 | 254 | 203 | 161 | 151 | 227 |
Currency Exchange Gain (Loss) | 216 | 87 | 32 | 311 | 363 | 389 |
Other Non Operating Income (Expenses) | -108 | -87 | 88 | -233 | 7 | 802 |
EBT Excluding Unusual Items | 6,497 | 6,545 | 6,277 | 3,066 | 4,853 | 8,840 |
Gain (Loss) on Sale of Investments | 51 | 57 | 319 | 66 | 4 | 1,261 |
Gain (Loss) on Sale of Assets | 2,661 | 1,490 | 2 | - | 123 | 30 |
Asset Writedown | -3,350 | -3,235 | -626 | -6,835 | -167 | -613 |
Other Unusual Items | -351 | -351 | -1 | -1 | 163 | -295 |
Pretax Income | 5,508 | 4,506 | 5,971 | -3,704 | 4,976 | 9,223 |
Income Tax Expense | 1,895 | 1,629 | 824 | 3,091 | 2,368 | 2,119 |
Earnings From Continuing Operations | 3,613 | 2,877 | 5,147 | -6,795 | 2,608 | 7,104 |
Minority Interest in Earnings | -143 | -125 | -134 | -297 | -264 | -357 |
Net Income | 3,470 | 2,752 | 5,013 | -7,092 | 2,344 | 6,747 |
Net Income to Common | 3,470 | 2,752 | 5,013 | -7,092 | 2,344 | 6,747 |
Net Income Growth | -28.75% | -45.10% | - | - | -65.26% | - |
Shares Outstanding (Basic) | 15 | 16 | 16 | 16 | 16 | 17 |
Shares Outstanding (Diluted) | 17 | 17 | 18 | 16 | 16 | 17 |
Shares Change | -3.43% | -2.81% | 10.93% | 0.11% | -2.34% | -1.52% |
EPS (Basic) | 225.23 | 176.39 | 309.16 | -437.64 | 144.81 | 407.06 |
EPS (Diluted) | 200.09 | 157.55 | 278.91 | -437.64 | 144.81 | 407.06 |
EPS Growth | -26.21% | -43.51% | - | - | -64.43% | - |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | - | 8,409 | 5,057 | 2,842 | -1,885 | 1,503 |
Free Cash Flow Per Share | - | 481.34 | 281.32 | 175.38 | -116.45 | 90.68 |
Dividend Per Share | 145.000 | 145.000 | 135.000 | 70.000 | 75.000 | 70.000 |
Dividend Growth | 7.41% | 7.41% | 92.86% | -6.67% | 7.14% | 366.67% |
Gross Margin | 24.83% | 25.42% | 24.03% | 20.53% | 22.04% | 26.26% |
Operating Margin | 7.56% | 7.92% | 7.22% | 3.58% | 5.26% | 9.35% |
Profit Margin | 4.19% | 3.38% | 5.94% | -8.64% | 2.79% | 8.42% |
Free Cash Flow Margin | - | 10.32% | 5.99% | 3.46% | -2.25% | 1.88% |
EBITDA | 10,017 | 10,193 | 9,743 | 7,297 | 8,825 | 11,828 |
EBITDA Margin | 12.10% | 12.52% | 11.54% | 8.89% | 10.52% | 14.76% |
D&A For EBITDA | 3,763 | 3,740 | 3,649 | 4,354 | 4,417 | 4,333 |
EBIT | 6,254 | 6,453 | 6,094 | 2,943 | 4,408 | 7,495 |
EBIT Margin | 7.56% | 7.92% | 7.22% | 3.58% | 5.26% | 9.35% |
Effective Tax Rate | 34.41% | 36.15% | 13.80% | - | 47.59% | 22.98% |